Joel Erblich | Mount Sinai

About Me

Dr. Erblich is a behavioral health scientist experienced in cancer prevention and control, with an emphasis on nicotine and alcohol dependence. He received a PhD in clinical psychology from the University of Southern California, completed a clinical internship at UCLA, and completed postdoctoral fellowships in biobehavioral medicine at both the Memorial-Sloan Kettering Cancer Center and Mount Sinai. He has been a PI on numerous research grants and career development awards from diverse funding agencies, including the NCI, NIDA, American Cancer Society, Department of Defense Breast Cancer Research Program, PCORI, and others. In addition, Dr. Erblich was involved, and continues to be involved, in numerous multidisciplinary training and education grants, as well as several educational grants aimed at disseminating evidence-based behavioral interventions to manage cancer treatment side effects. Finally, because of his experience in biostatistics, Dr. Erblich currently serves as the methodologist on several R01 grants relating to behavioral medicine. Dr. Erblich is also a licensed psychologist in New York and New Jersey.

Language

English

Position

LECTURER | Population Health Science and Policy, LECTURER | Oncological Sciences

Research Topics

Addiction, Behavioral Health, Biostatistics, Cancer

Research

Dr. Erblich's research focuses on the interactions among emotional, cognitive, behavioral and genetic factors in cancer prevention and control. Current efforts focus on nicotine dependence and alcoholism. Dr. Erblich's research takes a multidisciplinary-translational approach, with hypotheses driven by both the human and animal literatures that have contributed to the current understanding of motivations for drug use. The overall goal of Dr. Erblich's research in this area is to better understand how cognitive-behavioral, affective, and genetic factors impact smoking behavior. The research thus draws upon behavioral principles, such as personality, conditioning, and stress reactivity, as well as molecular biological principles, including genetic and cellular mechanisms of dopamine transmission to better understand motivation for substance use. Dr. Erblich is also a trained biostatistician and collaborates on a diverse portfolio of NIH-funded projects in cancer prevention and control, as well as projects that focus on the intergation of behavior and health more broadly.

Locations

Icahn (East) Building Floor 2nd Fl Room Room 2-70, 1425 Madison Ave, New York, NY, 10029

212-659-5516

Publications

Publications:56

Selected Publications

View All Publications

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Erblich during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Outside Employment

City University of New York (CUNY)

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.

Joel Erblich, PhD

About Me

Language

Position

Research Topics

About Me

Language

Position

Research Topics

Research

Locations

Publications

Selected Publications

Industry Relationships